Fri, May 17, 2024
Thu, May 16, 2024
Wed, May 15, 2024

Danielle Antalffy Downgraded (TMCI) to Hold and Decreased Target to $6.5 on, May 16th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. nd-decreased-target-to-6-5-on-may-16th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Danielle Antalffy of UBS, Downgraded "Treace Medical Concepts, Inc." (TMCI) to Hold and Decreased Target from $16 to $6.5 on, May 16th, 2024.

Danielle has made no other calls on TMCI in the last 4 months.



There are 5 other peers that have a rating on TMCI. Out of the 5 peers that are also analyzing TMCI, all agree with Danielle's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Drew Ranieri of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $5.5 on, Wednesday, May 8th, 2024
  • Richard Newitter of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $7 on, Wednesday, May 8th, 2024
  • Rick Wise of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Wednesday, May 8th, 2024
  • Robbie Marcus of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $8 on, Wednesday, May 8th, 2024
  • Ryan Zimmerman of "BTIG" Downgraded from Strong Buy to Hold on, Wednesday, May 8th, 2024

Publication Contributing Sources